BON SECOURS SOUTHSIDE MEDICAL CENTER
1. Target Overview & Investment Thesis
BON SECOURS SOUTHSIDE MEDICAL CENTER is a 300-bed suburban community hospital in nan, VA with $262.2M in net patient revenue and a 0.7% operating margin. The hospital serves a payer mix of 30.4% Medicare, 2.8% Medicaid, and 66.7% commercial.
Thesis: Undervalued. Our ML models identify $19.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.7% to 8.1% (+736bps).
| Net Revenue HCRIS | $262.2M |
| Current EBITDA COMPUTED | $1.9M |
| Operating Margin COMPUTED | 0.7% |
| Occupancy HCRIS | 54.1% |
| Revenue / Bed COMPUTED | $874K |
| Net-to-Gross HCRIS | 11.7% |
| Distress Probability ML | 46.1% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 0.7% places it below the state median. Among 26 size-comparable peers (150-600 beds), the median margin is 6.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (150-600), prioritizing same-state peers. 26 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BON SECOURS SOUTHSIDE MEDICAL (Target) | VA | 300 | $262.2M | 0.7% |
| SENTARA NORFOLK GENERAL HOSPIT | VA | 472 | $1.34B | 4.9% |
| RIVERSIDE REGIONAL MEDICAL CEN | VA | 379 | $963.3M | -20.1% |
| WINCHESTER MEDICAL CENTER | VA | 455 | $694.7M | -5.8% |
| ST. MARYS HOSPITAL | VA | 363 | $688.9M | 13.3% |
| VIRGINIA HOSPITAL CENTER ARLIN | VA | 336 | $624.4M | 1.8% |
| MARY WASHINGTON HOSPITAL | VA | 440 | $552.1M | 1.7% |
| CHILDRENS HOSPITAL OF THE KING | VA | 202 | $546.2M | -9.9% |
| SENTARA LEIGH HOSPITAL | VA | 274 | $511.5M | 14.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $5.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $168K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.9M |
| + RCM Uplift | +$19.3M |
| Pro Forma EBITDA | $21.2M |
| Current Margin | 0.7% |
| Pro Forma Margin | 8.1% |
| WC Released (1x) | $10.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $3.0M | $205.7M | 69.40x | 133.5% |
| Base (11x exit) | 10.0x | 11.0x | $3.0M | $227.3M | 76.67x | 138.2% |
| Bull Case | 9.0x | 11.0x | $2.7M | $292.0M | 109.42x | 155.8% |
| Bull (12x exit) | 9.0x | 12.0x | $2.7M | $319.3M | 119.67x | 160.4% |
| Bear Case | 11.0x | 10.0x | $3.3M | $108.3M | 33.20x | 101.5% |
| Bear (11x exit) | 11.0x | 11.0x | $3.3M | $120.2M | 36.85x | 105.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 26 hospitals with 150-600 beds
- Same-state prioritization (n=27)
- Comp margins: P25=-2.5% / P50=6.0% / P75=14.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.